![Kimball Hall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kimball Hall
Amministratore Delegato presso INNOCOLL HOLDINGS PLC
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Kimball Hall
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 20 | |
Holding Company | Pharmaceuticals: Major | 6 | |
Syntacoll Gmbh
![]() Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kimball Hall tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
MedImmune Vaccines, Inc.
![]() MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | General Counsel | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Haas School of Business | College/University | Undergraduate Degree Masters Business Admin | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
Orbus Therapeutics, Inc.
![]() Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
BIOTECanada
![]() BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
Ascendis Pharma, Inc. | Director/Board Member | ||
The California State University | College/University | Undergraduate Degree | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | General Counsel | |
Sectoral Asset Management, Inc.
![]() Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral Asset Management, Inc. (Sectoral) is an investment management firm headquartered in Montréal, Canada. The firm was founded in 2000 by Jérôme G. Pfund and Michael J. Sjöström. They are a wholly-owned subsidiary of Sectoral Asset Management Holding Ltd. in Hong Kong. Sectoral manages public and private equity healthcare strategies for investors around the world. Their clients include sovereign wealth funds, private banks, and family offices. In addition, they have long-standing sub-advisory relationships with institutional investors in Europe and Asia. | Investment Managers | Chief Investment Officer | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
AlloCure, Inc.
![]() AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Chief Executive Officer | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
Kleiner Perkins Caufield & Byers LLC
![]() Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Investment Managers | Consultant / Advisor | |
MACROGENICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Broadhaven Capital Partners (Private equity)
![]() Broadhaven Capital Partners (Private equity) Investment ManagersFinance Broadhaven Capital Partners (Broadhaven Capital Partners) is a private equity subsidiary of Broadhaven Capital Partners LLC founded in 2009 by Gregory Allen Phillips and Gerard von Dohlen. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Franklin Templeton Cos. LLC | Corporate Officer/Principal | ||
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director/Board Member | |
Facet, Inc.
![]() Facet, Inc. Information Technology ServicesTechnology Services Facet, Inc. manufactures software for creating and maintaining libraries. The private company is based in Milwaukee, WI and has no subsidiaries. | Information Technology Services | Director/Board Member | |
Abingworth LLP
![]() Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
Launch Therapeutics, Inc.
![]() Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member | |
McGill University | College/University | Doctorate Degree | |
RainDance Technologies, Inc.
![]() RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Global Virus Network
![]() Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
Sectoral Asset Management Inc (Private Equity)
![]() Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec. | Investment Managers | Private Equity Investor | |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
Stati Uniti | 34 |
Canada | 9 |
Regno Unito | 3 |
Settori
Health Technology | 20 |
Finance | 11 |
Consumer Services | 9 |
Commercial Services | 4 |
Technology Services | 2 |
Posizioni
Director/Board Member | 118 |
Corporate Officer/Principal | 38 |
Independent Dir/Board Member | 35 |
Undergraduate Degree | 19 |
Private Equity Investor | 14 |
Contatti più connessi
Insiders | |
---|---|
Patrick Enright | 41 |
Beth Seidenberg | 39 |
Kurt von Emster | 34 |
Maha Katabi | 28 |
Scott Morrison | 16 |
Andrew Cheng | 10 |
Robert M. Brenner | 8 |
Michael Morrissey | 8 |
William D. Turner | 7 |
Robert Sklans | 7 |
Marshall Fordyce | 6 |
Kelly Rauber | 5 |
Kerry Cooper | 5 |
Sean Grant | 5 |
Joseph Young | 5 |
- Borsa valori
- Insiders
- Kimball Hall
- Connessioni Società